首页 | 本学科首页   官方微博 | 高级检索  
检索        

肺癌患者淋巴细胞亚群在外周血中的表达及其与预后的关系
作者姓名:Luo J  Ling Z  Mao W
作者单位:浙江省肿瘤医院,浙江省肿瘤研究所,杭州,310022
基金项目:浙江省科技计划项目(No.2009C33143); 浙江省中医药优秀青年研究计划项目(No.2009YA016)资助~~
摘    要:背景与目的肺癌是最常见的恶性肿瘤之一,本研究旨在探讨肺癌患者外周血中淋巴细胞亚群的表达及与预后的关系。方法采用流式细胞仪检测221例原发性肺癌首诊患者外周血淋巴细胞亚群CD3+、CD4+、CD8+、CD4+/CD8+、CD19+、CD25+、CD44+及NK细胞所占比例,并与96例健康人的血标本对比,结合临床及随访资料进行统计分析。结果与健康对照组对比,肺癌患者淋巴细胞亚群8项指标中CD3+及CD8+明显低于健康对照组,CD4+/CD8+、CD19+、CD25+、CD44+及NK细胞明显高于健康对照组(P<0.05)。与非小细胞肺癌(non-small cell lung cancer,NSCLC)相比,小细胞肺癌(small cell lung cancer,SCLC)的CD8+明显升高而CD4+和CD4+/CD8+明显下降(P<0.05)。化疗后与化疗前相比CD3+明显上升,NK细胞、CD19+及CD44+明显下降(P<0.05),其中CD44+在化疗后表达不升高者有生存优势(P=0.021),而其余3项指标与患者预期生存无关。结论肺癌患者外周血淋巴细胞亚群普遍发生改变,CD44+在化疗后的改变可能与预后相关。

关 键 词:肺肿瘤  淋巴细胞亚群  化疗

Circulating lymphocyte subsets in patients with lung cancer and their prognostic value
Luo J,Ling Z,Mao W.Circulating lymphocyte subsets in patients with lung cancer and their prognostic value[J].Chinese Journal of Lung Cancer,2011,14(8):669-673.
Authors:Luo Jun  Ling Zhiqiang  Mao Weimin
Institution:Jun LUO,Zhiqiang LING,Weimin MAO Zhejiang Cancer Hospital,Zhejiang Cancer Research Institute,Hangzhou 310022,China
Abstract:Background and objective Lung cancer is one of the most common malignancies.The aim of this study is to investigate the relationship between the change of lymphocyte subsets in the peripheral blood of lung cancer patients and the survival rate.Methods Flow cytometry was used to measure the percentages of lymphocyte subsets(CD3+,CD4+,CD8+,CD4+/CD8+,CD19+,CD25+,CD44+,and NK cells) in peripheral blood obtained from 221 patients with primary lung cancer without any treatment and from 96 healthy blood donors as ...
Keywords:Lung neoplasms  Lymphocyte subsets  Chemotherapy  
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号